BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 64.70
arrow_downward
-1.52%(-1.00) 1D
Oct 13, 5:30:39 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHF 65.80
High
CHF 66.70
Low
CHF 64.50
Mkt. cap
869.74M
Avg. vol.
35.75K
Volume
15.70K
P/E ratio
16.89
52-wk high
CHF 70.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.44M
No. of employees
200
Open
CHF 65.80
High
CHF 66.70
Low
CHF 64.50
Mkt. cap
869.74M
Avg. vol.
35.75K
Volume
15.70K
P/E ratio
16.89
52-wk high
CHF 70.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.44M
No. of employees
200
News stories
From web sources and news partners
Seeking Alpha
·
1 hour ago
Biomea Fusion, Inc. (BMEA) Discusses BMF-650 Phase I Topline Results and Potential for Separating GI Side Effects from Weight Loss - Slideshow (NASDAQ:BMEA) 2026-10-14
Yahoo Finance
·
18 minutes ago
The S&P 500 Just Hit a Record High. Here's Why History Says It's Still a Smart Time to Invest.
MarketBeat
·
14 minutes ago
X-Energy, Inc.'s (NASDAQ:XE) Lock-Up Period Set To Expire on October 21st
Bloomberg.com
·
7 hours ago
Asia Stocks to Gain on Signal for Fewer Fed Hikes: Markets Wrap
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil